Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Memoli

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nature Immunology|November 10, 2020
Proinflammatory IgG Fc structures in patients with severe COVID-19Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Proinflammatory IgG Fc structures in patients with severe COVID-19Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, et al.
Science Translational Medicine|October 14, 2021
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19Felice D'Agnillo, Kathie-Anne Walters, Yongli Xiao, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive PatientsJohn H Powers, Elizabeth D Bacci, M Lourdes Guerrero, et al.
Plos One|March 23, 2018
Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)John H Powers, Elizabeth D Bacci, Nancy K Leidy, et al.
Personality and Individual Differences|July 14, 2026
The effect of personality on likelihood of contracting SARS-CoV-2 in the United StatesJoshua K Wood, Sara J Weston, David M Condon, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United StatesTran B Ngo, Maria Karkanitsa, Kenneth M Adusei, et al.
Medrxiv : the Preprint Server for Health Sciences|October 31, 2023
Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 MonthsMaria Karkanitsa, Yan Li, Shannon Valenti, et al.
The New England Journal of Medicine|April 11, 2014
Glycosylation, hypogammaglobulinemia, and resistance to viral infectionsMohammed A Sadat, Susan Moir, Tae-Wook Chun, et al.
Science Translational Medicine|June 23, 2021
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United StatesHeather Kalish, Carleen Klumpp-Thomas, Sally Hunsberger, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nature Immunology|November 10, 2020
Proinflammatory IgG Fc structures in patients with severe COVID-19Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Proinflammatory IgG Fc structures in patients with severe COVID-19Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, et al.
Science Translational Medicine|October 14, 2021
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19Felice D'Agnillo, Kathie-Anne Walters, Yongli Xiao, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive PatientsJohn H Powers, Elizabeth D Bacci, M Lourdes Guerrero, et al.
Plos One|March 23, 2018
Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)John H Powers, Elizabeth D Bacci, Nancy K Leidy, et al.
Personality and Individual Differences|July 14, 2026
The effect of personality on likelihood of contracting SARS-CoV-2 in the United StatesJoshua K Wood, Sara J Weston, David M Condon, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United StatesTran B Ngo, Maria Karkanitsa, Kenneth M Adusei, et al.
Medrxiv : the Preprint Server for Health Sciences|October 31, 2023
Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 MonthsMaria Karkanitsa, Yan Li, Shannon Valenti, et al.
The New England Journal of Medicine|April 11, 2014
Glycosylation, hypogammaglobulinemia, and resistance to viral infectionsMohammed A Sadat, Susan Moir, Tae-Wook Chun, et al.
Science Translational Medicine|June 23, 2021
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United StatesHeather Kalish, Carleen Klumpp-Thomas, Sally Hunsberger, et al.
Pageof 7